Pharmacyte Biotech Inc

Penny Stocks Biotech Stocks Healthcare Stocks

$0.73

-0.04 (-5.03%)

As of Jun 29, 10:42 PM ET ·

Analyst Consensus

Strong Sell

Analysts

Moderate

Coverage

Buy 0 0%

Hold 3 50%

Sell 3 50%

Price Target

Analyst Price Target +3,693.4% upside

Low Target $20.43

Average Target $27.73

High Target $35.07

Current Price $0.73

Current
$0.73

Target
$27.73

$20.43 $27.73 avg $35.07

Scenario Analysis

Bear Case

$20.43

2,694.8%

Low target

Base Case

$27.73

+3,693.4%

Avg target

Bull Case

$35.07

+4,697.5%

High target

Risk/Reward

1.7x

Balanced

Price in Context

52-Week High

$1.51

-51.6% from high

52-Week Low

$0.63

+16.0% from low

Target vs 52W High

$27.73

+1,736.4% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	40	78%	$257.58	+2.4%
AMGN Amgen Inc	Hold	44	50%	$190.87	-47.3%
GILD Gilead Sciences Inc	Strong Buy	39	82%	$362.68	+187.1%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	40	83%	$438.34	-11.8%
REGN Regeneron Pharmaceuticals	Buy	38	71%	$76.80	-87.7%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	37	76%	$102.31	-66.0%
RVMD Revolution Medicines Inc	Strong Buy	27	96%	$114.11	-39.1%
NTRA Natera Inc	Strong Buy	27	89%	$142.91	-47.4%